Figure 7.
ΔdblGATA BM has reduced repopulation potential. (A) The BM of WT CD45.1+ mice was ablated by intraperitoneal injections of treosulfan, and mice were then IV injected with 8 × 106 BM cells, which were a 1:1 mixture of either WT CD45.1+ plus WT CD45.2+ BM or WT CD45.1+ plus ΔdblGATA CD45.2+ BM. After at least 8 weeks of reconstitution, mice were immunized with PLP180-199 to induce EAE and sacrificed on day 16 after immunization for the analysis of peripheral blood and CNS mononuclear cells. (B-G) Analysis of experiment described in panel A. (B) CD45.1+ and CD45.2+ cells among PBMCs of mixed chimera mice. (C) Frequency of CD45.2+ cells divided by frequency of CD45.1+ cells. (D) CD45.1+ and CD45.2+ cells among CD45+Sall1− (nonmicroglia) cells in the CNS during EAE. (E) Frequency of CD45.2+ cells divided by frequency of CD45.1+ cells. Cells included in analysis were pregated on CD45+Sall1− (CNS-infiltrating immune cells). (F) Ly6ChiCCR2+ monocytes among the gated CD45.1+ or CD45.2+ CD11b+ cells from the CNS. (G) Ratios of frequency of CD45.2+Ly6C+CCR2+ monocytes in CD45.2+CD11b+ cells divided by frequency of CD45.1+Ly6C+CCR2+ monocytes in CD45.1+CD11b+ cells. Significance was determined by 2-tailed t test. Error bars are SEM. N = 11 to 12 mice per group; data were compiled from 2 independent experiments.

ΔdblGATA BM has reduced repopulation potential. (A) The BM of WT CD45.1+ mice was ablated by intraperitoneal injections of treosulfan, and mice were then IV injected with 8 × 106 BM cells, which were a 1:1 mixture of either WT CD45.1+ plus WT CD45.2+ BM or WT CD45.1+ plus ΔdblGATA CD45.2+ BM. After at least 8 weeks of reconstitution, mice were immunized with PLP180-199 to induce EAE and sacrificed on day 16 after immunization for the analysis of peripheral blood and CNS mononuclear cells. (B-G) Analysis of experiment described in panel A. (B) CD45.1+ and CD45.2+ cells among PBMCs of mixed chimera mice. (C) Frequency of CD45.2+ cells divided by frequency of CD45.1+ cells. (D) CD45.1+ and CD45.2+ cells among CD45+Sall1 (nonmicroglia) cells in the CNS during EAE. (E) Frequency of CD45.2+ cells divided by frequency of CD45.1+ cells. Cells included in analysis were pregated on CD45+Sall1 (CNS-infiltrating immune cells). (F) Ly6ChiCCR2+ monocytes among the gated CD45.1+ or CD45.2+ CD11b+ cells from the CNS. (G) Ratios of frequency of CD45.2+Ly6C+CCR2+ monocytes in CD45.2+CD11b+ cells divided by frequency of CD45.1+Ly6C+CCR2+ monocytes in CD45.1+CD11b+ cells. Significance was determined by 2-tailed t test. Error bars are SEM. N = 11 to 12 mice per group; data were compiled from 2 independent experiments.

Close Modal

or Create an Account

Close Modal
Close Modal